Lanzotyle 30 Injection: Your Partner for a High-Demand PCD Pharma Business

Lansoprazole Injection: A Critical Component in Modern Gastroenterology

The Growing Market for Injectable Anti-Ulcer Medications

Why Lanzotyle 30 is a Profitable Choice for Distributors

The Advantage of Partnering with a Quality-Focused Pharma Company
Join Our Pharma Franchise for a Lucrative Opportunity

Home/Products /lansoprazole-30mg-injection

Lanzotyle 30 Injection

Composition : Lansoprazole (30mg) Injection

Dosage Form : Injection

Packaging Type : Vial + Water

Packaging : 30ml

Price : ₹1/-

Lanzotyle 30 Injection, with its active ingredient Lansoprazole (30mg), is a potent proton pump inhibitor (PPI) designed to meet the critical needs of patients suffering from severe gastrointestinal issues. As an injectable formulation, it is a vital tool in hospital and critical care settings for the treatment of peptic ulcers, gastroesophageal reflux disease (GERD), and to prevent stress ulcers in seriously ill patients who cannot receive oral medication. The demand for such a specialized and effective product is consistently high within the institutional and hospital supply chain, making it an essential addition to any distributor’s portfolio.

Read More

About the Product

Lanzotyle 30 Injection, with its active ingredient Lansoprazole (30mg), is a potent proton pump inhibitor (PPI) designed to meet the critical needs of patients suffering from severe gastrointestinal issues. As an injectable formulation, it is a vital tool in hospital and critical care settings for the treatment of peptic ulcers, gastroesophageal reflux disease (GERD), and to prevent stress ulcers in seriously ill patients who cannot receive oral medication. The demand for such a specialized and effective product is consistently high within the institutional and hospital supply chain, making it an essential addition to any distributor’s portfolio.

May include headache, diarrhea, nausea, abdominal pain, or dizziness. Rarely, allergic reactions or changes in liver function tests may occur.

Peptic ulcer disease (gastric and duodenal ulcers) GERD (Gastroesophageal reflux disease) Zollinger-Ellison syndrome Prevention of stress-induced gastritis or ulcers in critically ill patients

Use only under medical supervision. Administer via intravenous route as prescribed. Monitor for signs of allergic reactions or electrolyte imbalance during prolonged use.

Store below 25°C in a cool, dry place away from light. Protect the vial from moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation